Sat.Oct 29, 2022 - Fri.Nov 04, 2022

article thumbnail

Protecting treatment advances for National Breast Cancer Awareness Month

PhRMA

Since the 1980s, October has been recognized as National Breast Cancer Awareness Month — an opportunity for us to unite as a community to honor those who have had breast cancer and raise awareness about progress biopharmaceutical researchers have made towards treating the disease.

241
241
article thumbnail

Breaking Down the Benefits and Risk of Co-Administration of COVID-19 and Flu Vaccines

Drug Topics

Help protect patients by giving them the facts about getting both shots at once to save them a trip and increase rates of vaccination.

Vaccines 212
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Wearables Made for the Pharmaceutical Industry

Pharmacy Times

Purpose-built assisted reality solutions help streamline processes and maintain regulatory compliance from the laboratory to the factory floor.

181
181
article thumbnail

Pfizer, BioNTech report bivalent Covid-19 booster more protective than original vaccine

STAT

New data from Pfizer and BioNTech on their bivalent Covid-19 vaccine suggests the updated product may be more protective against more recent Omicron subvariants than the original version of the vaccine, the companies said in a statement released Friday. The companies said the levels of neutralizing antibodies that target the BA.4 and BA.5 subvariants of the SARS-CoV-2 virus were four-fold higher in people aged 55 and older who received the bivalent booster than in similarly aged people who recei

Vaccines 138
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

PhRMA submission to USTR calls for urgent defense of American innovation abroad

PhRMA

The United States leads the world in medicine research, development and manufacturing, and international trade delivers those medicines to patients around the globe. But trade barriers imposed in many countries impede the ability of U.S. biopharmaceutical companies to export even more American-made medicines and employ even more scientists, researchers and factory workers.

197
197
article thumbnail

Crisis (Not) Averted

Drug Topics

It’s too late for retail chain pharmacies to engage in the preventive maintenance that would have spared them the worst of the Great Resignation.

187
187

More Trending

article thumbnail

Opinion: How the world can end Covid-19 as a public health threat

STAT

The journal Nature published today global consensus recommendations to end Covid-19 as a public health threat. It took a panel of almost 400 independent-thinking scientists, doctors, and representatives of community groups from more than 100 countries (we were among the co-chairs) some 14 months to develop and agree on these recommendations. There have been times when we wondered if it was worth the effort.

138
138
article thumbnail

Verge Genomics takes AI-sourced drug for ALS into clinic

pharmaphorum

Verge Genomics has joined a select group of biotechs who have taken a drug discovered and developed using artificial intelligence into human testing. The small-molecule PIKfyve inhibitor – called VRG50635 – has been administered to the first subject in the phase 1 trial involving healthy volunteers, according to the San Francisco-based biotech, which was founded in 2015 by Alice Zhang and Jason Chen.

article thumbnail

Flu Shots and Ischemic Stroke Risk in Older Adults

Drug Topics

Recently published research reveals an important benefit for middle-aged and older adults: a reduction in ischemic stroke risk.

201
201
article thumbnail

Improving the Patient-Pharmacist Relationship in Four Easy Steps

Pharmacy Times

Pharmacists are the premier medication experts within health care, who understand more about medication interactions than most physicians and have the unique ability to prevent complications, improve adherence, and save lives.

139
139
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

GSK speeds up the race to bring first RSV vaccine for older adults to market

Pharmaceutical Technology

After decades of setbacks, the respiratory syncytial virus (RSV) vaccine field has bounced back with positive Phase III trial results in older adults. There are currently five players in the race, with vaccines in Phase III of development from GlaxoSmithKline (GSK) , Pfizer , Johnson & Johnson , Moderna and Bavarian Nordic. However, recent data from GSK’s sub-unit vaccine, GSK-3844766A, have pushed the candidate to the top, with the highest efficacy demonstrated in a pivotal trial to date.

Vaccines 135
article thumbnail

Could digital therapeutics provide a solution against opioid abuse?

pharmaphorum

Digital therapeutics are rapidly coming into the foreground to treat a variety of conditions. Ben Hargreaves discovers how chronic pain could be a key area for digital therapeutics, as they offer non-addictive and effective relief from the condition. The struggle to manage pain for individuals has been one that goes back a long way in history, with one of the earliest recorded medical prescriptions being for opium.

FDA 135
article thumbnail

Science Communication Tips for Pharmacists

Drug Topics

Pharmacists can help educate patients as they try to analyze scientific information shared via the news or social media.

article thumbnail

Proof-of-Concept Study Shows Positive Results for Novel HIV Treatment

Pharmacy Times

Investigational broadly neutralizing antibody shows promise as potential as a first-in-class treatment option for HIV.

171
171
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Here’s why we’re not prepared for the next wave of biotech innovation

STAT

T he first time I remember hearing the words “biology’s century,” it was a sales pitch. I was standing by the Long Island Sound in Sachem’s Head, Conn., in the shadow of an 11-foot-tall granite Stonehenge replica built by Jonathan Rothberg, a biotech entrepreneur, as he talked up his newest gadget, a tabletop DNA sequencer.

FDA 129
article thumbnail

“Universal” CRISPR-edited T cells improve resistant leukaemia

European Pharmaceutical Review

Researchers at Great Ormond Street Hospital for Children (GOSH) and University College London (UCL) Great Ormond Street Institute of Child Health (UCL GOS ICH) have used “universal” CRISPR-edited cells in humans for the first time to treat B-cell acute lymphoblastic leukaemia (B-ALL) child patients with engineered donor T cells. The treatment did not require matching donor cells, a major step in developing gene-edited cells for cancer treatment.

Hospitals 127
article thumbnail

New Pneumococcal Vaccine Shows Promise in Preventing Disease In Adults

Drug Topics

Phase I/II data indicate that new investigative pneumococcal conjugate vaccine shows efficacy in preventing disease in adults.

Vaccines 187
article thumbnail

If You Want to Know Where Pharmacists' Roles Are Heading, Follow Patients

Pharmacy Times

Last year in particular, pharmacists played a greater role in patient care with an increased workload as they connected patients, providers, and payers.

article thumbnail

STAT+: A turnaround for Editas Medicine, a CRISPR laggard, hinges on updates on key treatments

STAT

Editas Medicine’s new leadership team on Wednesday reiterated a promise to deliver clinical updates on two CRISPR-based treatments before the end of the year — data the troubled biotech hopes will ease investor doubts about its gene-editing technology. Other CRISPR companies command multibillion-dollar valuations, but Editas, one of the originals, trades below its IPO price after years of management upheaval and clinical delay.

121
121
article thumbnail

Why blockchain is big pharma’s big focus

pharmaphorum

To address the supply chain vulnerabilities of the pharma industry, an innovative, collaborative blockchain-based system could help to keep track of drugs in transit and ensure they are stored in the correct conditions. The pace of technological advancement and focus in this area suggests that such a solution could be coming soon. While most supply chains were impacted by the Covid-19 pandemic, the demands it placed on pharmaceutical and medical supply chains were immense and underlined the impo

article thumbnail

Increased Scanning with CGM Improves Glucose Control in T1D

Drug Topics

Research shows that an increase in intermittent scanning helps improve glycemic control and reduce the fear of hypoglycemia.

163
163
article thumbnail

Relationship Between Psoriasis, Kidney Damage Remains Unclear

Pharmacy Times

Psoriasis and end-stage renal disease are believed to share multiple pathogenic pathways, including various cytokines, reactive oxygen species, and psoriasis medications.

139
139
article thumbnail

Telehealth startups prescribing ketamine at home are stirring concern

STAT

Since the late ’90s, Kathy Wallace has been battling major depression with a series of drugs — first Prozac, then three others, and back again to Prozac. But in the last six months, nothing seemed to be helping. So her psychiatrist recommended something new: Spravato, a nasal spray approved in 2019 that delivers a drug similar to the hallucinogen ketamine.

Labelling 118
article thumbnail

CVS Health to sell Omnicare

Drug Store News

In an SEC filing on Wednesday CVS said that it is “determined that its LTC business was no longer a strategic asset, and during the third quarter of 2022 committed to a plan to sell.

119
119
article thumbnail

What Do the Midterms Mean for Pharmacy?

Drug Topics

Independent pharmacists stand to gain—or lose—depending on what happens at the polls in November 2022.

187
187
article thumbnail

Respiratory Syncytial Virus Infection in the Pediatric Population

Pharmacy Times

Infection with RSV can take a variety of forms, ranging from a mild upper respiratory tract infection to severe, life-threatening acute respiratory failure.

144
144
article thumbnail

Pfizer records 6% decline in revenue in Q3 2022

Pharmaceutical Technology

Pfizer has reported a 6% decline in revenue to $22.6bn in the third quarter (Q3) of 2022 as against $24bn in the same quarter last year. In the quarter, revenues rose 2% operationally on omitting contributions from Covid-19 therapies, Paxlovid and Comirnaty. Reduction in revenues from Comirnaty outside the US and reduced revenues for some Comirnaty-linked manufacturing works carried out on behalf of BioNTech, Xeljanz and Sutent worldwide were the key drivers that contributed to the revenue dec

116
116
article thumbnail

STAT+: A ‘blank check’: Bill to boost antibiotic development blasted as a ‘flawed’ giveaway to pharma

STAT

Amid mounting concern over antibiotic resistance, a coalition of academics and advocacy groups is urging Congress not to pass legislation to reward drug companies for developing new treatments, because they argue the bill fails to require acceptable clinical trial standards and is tantamount to a giveaway to the pharmaceutical industry. The legislation, known as the Pasteur Act, would encourage drug development by creating a subscription-style business model in which the U.S. government offers u

article thumbnail

Pharmacists Challenged With Amoxicillin, Adderall Shortages

Drug Topics

Shortages are leaving patients in the lurch.

201
201
article thumbnail

Finerenone May Protect Patients With Chronic Kidney Disease From Pneumonia-Related Severe Adverse Events

Pharmacy Times

The drug is a selective, nonsteroidal mineralocorticoid receptor antagonist found to also protect against COVID-19 and pneumonia-related adverse events in patients with diabetes.

132
132
article thumbnail

Lilly says Mounjaro launch is “viral in nature”

pharmaphorum

One of the highlights of Eli Lilly’s third-quarter results was the rapid uptake of new type 2 diabetes therapy Mounjaro, which added more than $97 million in US sales alone in what has been described as “viral” take-up by the drugmaker. Lilly’s head of diabetes, Mike Mason, said on the company’s results call that the rollout of Mounjaro (tirzepatide) was “really unprecedented” for a new diabetes therapy in the US, and had been driven by “tremendous

FDA 105
article thumbnail

How doulas could help prevent the harms that can happen during childbirth

STAT

When Tamiya Griffin was expecting her first child in 2014, she had what she thought was a straightforward plan: deliver at the hospital down the road, the same place her mother gave birth to her. But when Griffin, then a 22-year-old senior in college, went into labor a few weeks early, she had to undergo an emergency C-section.  “And that was not a part of my plan.

Hospitals 107
article thumbnail

While DCTs get all the hype, some industry insiders say the future is a digital hybrid

PharmaVoice

Leaders at Veeva believe the wording around decentralized trials has been exaggerated, and that a bigger-picture outlook is important as the pandemic winds down.

105
105
article thumbnail

Expert Suggests That Pharmacists Should Learn More About Dialysis

Pharmacy Times

Education, awareness, and more training may help more pharmacists and kidney patients consider home dialysis as an effective treatment option, said an expert on November 4 at ASN Kidney Week in Orlando, Florida.

132
132